Reactivation of retinopathy of prematurity after bevacizumab injection

Archives of Ophthalmology

Volumn 130, Issue 8, 2012, Pages 1000-1006

  Hu, Jennifer ^a   Blair, Michael P ^a,b   Shapiro, Michael J ^a,b   Lichtenstein, Steven J ^c   Galasso, John M ^b   Kapur, Rashmi ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

AGE; ARTICLE; CLINICAL ARTICLE; HUMAN; INFANT; MONOTHERAPY; NEWBORN; POSTMENSTRUAL AGE; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; DISEASE PROGRESSION; FLUORESCEIN ANGIOGRAPHY; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTRAVITREAL INJECTIONS; LASER COAGULATION; RECURRENCE; RETINAL DETACHMENT; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84864414045     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.592     Document Type: Article

References (11)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106(4):471-479.
2. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003; 121(12):1684-1694.
3. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10(2):133-140. (Pubitemid 46440629)
4. Smith LEH. Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl. 2002; 91(437):26-28. (Pubitemid 34876123)
5. Mintz-Hittner HA, Best LM. Antivascular endothelial growth factor for retinopathy of prematurity. Curr Opin Pediatr. 2009;21(2):182-187.
6. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603-615.
7. Hoang QV, Kiernan DF, Chau FY, Shapiro MJ, Blair MP. Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010;128(8):1080-1081.
8. Patel R, Blair MP, Shapiro MJ, Lichtenstein SJ. Significant treatment failure with intravitreal bevacizumab for retinopathy of prematurity. Arch Ophthalmol. In press.
9. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102 (8):1130-1134.
10. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991-999.
11. Moshfeghi DM, Berrocal AM. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology. 2011;118(7):1227-1228.